Share on LinkedInShare on LinkedIn

ARTICLE · 15 OCTOBER 2024

Retractable Technologies, Inc. Contests Section 301 Tariff Increase, Files Complaint

Crowell & Moring LLP
Crowell & Moring LLP
Contributor
Crowell & Moring LLP

Crowell & Moring LLP

Crowell & Moring’s Doha office is a full service legal practice that serves as the firm’s regional...

View firm profile
Explore more from Crowell & Moring LLP

On September 26, 2024, Texas-based syringe importer Retractable Technologies, Inc. ("Retractable") filed a complaint before the United States Court of International Trade contesting the Office...

United StatesInternational Law

On September 26, 2024, Texas-based syringe importer Retractable Technologies, Inc. ("Retractable") filed a complaint before the United States Court of International Trade contesting the Office of the United States Trade Representative's (USTR) 100 percent tariff rate on imported needles and syringes from China. The tariff increase became effective on September 27, 2024. In conjunction with the complaint, Retractable Technologies, Inc., also filed a motion for a temporary restraining order requesting the court suspend application of the tariff increase while the litigation is pending.

This action comes after USTR recently announced higher duties for needles and syringes from the previously proposed 50 percent to 100 percent as part its statutory four-year review of tariffs imposed on imported Chinese goods under Section 301 of the Trade Act of 1974.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from